Law360, New York (August 08, 2011, 10:11 PM ET) -- Abbott Laboratories sought Friday to overturn a $3.5 million jury verdict in a dispute with GlaxoSmithKline PLC over a licensing deal for Norvir, having already fought off GSK's antitrust challenge over its decision to drastically raise prices for the HIV drug.
The drugmaker asked U.S. District Judge Claudia Wilken to set aside the verdict that Abbott broke an implied covenant of good faith and fair dealing when it raised the price for Norvir nearly four-fold a year after entering into a licensing agreement allowing GSK to...
Abbott Fights $3.5M Verdict In GSK Suit Over Norvir
To view the full article, take a free trial now.
